These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
203 related items for PubMed ID: 8059779
1. NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis. Denning DW, Lee JY, Hostetler JS, Pappas P, Kauffman CA, Dewsnup DH, Galgiani JN, Graybill JR, Sugar AM, Catanzaro A. Am J Med; 1994 Aug; 97(2):135-44. PubMed ID: 8059779 [Abstract] [Full Text] [Related]
2. Analysis of compassionate use itraconazole therapy for invasive aspergillosis by the NIAID Mycoses Study Group criteria. Stevens DA, Lee JY. Arch Intern Med; 1997 Sep 08; 157(16):1857-62. PubMed ID: 9290545 [Abstract] [Full Text] [Related]
3. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group. Patterson TF, Kirkpatrick WR, White M, Hiemenz JW, Wingard JR, Dupont B, Rinaldi MG, Stevens DA, Graybill JR. Medicine (Baltimore); 2000 Jul 08; 79(4):250-60. PubMed ID: 10941354 [Abstract] [Full Text] [Related]
4. Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS. Caillot D, Bassaris H, McGeer A, Arthur C, Prentice HG, Seifert W, De Beule K. Clin Infect Dis; 2001 Oct 15; 33(8):e83-90. PubMed ID: 11550120 [Abstract] [Full Text] [Related]
5. Intravenous itraconazole followed by oral itraconazole for the treatment of amphotericin-B-refractory invasive pulmonary aspergillosis. Caillot D. Acta Haematol; 2003 Oct 15; 109(3):111-8. PubMed ID: 12714819 [Abstract] [Full Text] [Related]
6. [Therapy of invasive aspergillosis with itraconazole: our own experiences and review of the literature]. Kreisel W. Mycoses; 1994 Oct 15; 37 Suppl 2():42-51. PubMed ID: 7609743 [Abstract] [Full Text] [Related]
7. Tracheobronchial aspergillosis in a patient with AIDS treated with aerosolized amphotericin B combined with itraconazole. Dal Conte I, Riva G, Obert R, Lucchini A, Bechis G, De Rosa G, Gioannini P. Mycoses; 1996 Oct 15; 39(9-10):371-4. PubMed ID: 9009661 [Abstract] [Full Text] [Related]
10. Itraconazole for the treatment of pulmonary aspergillosis in heart transplant recipients. Nanas JN, Saroglou G, Anastasiou-Nana MI, Kostis EB, Petrochilou-Paschou VP, Kontoyannis DA, Stamatelopoulos SF, Moulopoulos SD. Clin Transplant; 1998 Feb 15; 12(1):30-4. PubMed ID: 9541420 [Abstract] [Full Text] [Related]
11. Treatment of aspergillosis with itraconazole. Jennings TS, Hardin TC. Ann Pharmacother; 1993 Oct 15; 27(10):1206-11. PubMed ID: 8251691 [Abstract] [Full Text] [Related]
12. Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial. Winston DJ, Maziarz RT, Chandrasekar PH, Lazarus HM, Goldman M, Blumer JL, Leitz GJ, Territo MC. Ann Intern Med; 2003 May 06; 138(9):705-13. PubMed ID: 12729424 [Abstract] [Full Text] [Related]
13. Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. French Cooperative Study Group on Aspergillosis in AIDS. Lortholary O, Meyohas MC, Dupont B, Cadranel J, Salmon-Ceron D, Peyramond D, Simonin D. Am J Med; 1993 Aug 06; 95(2):177-87. PubMed ID: 8395142 [Abstract] [Full Text] [Related]
14. Itraconazole prophylaxis for invasive gingival aspergillosis in neutropenic patients with acute leukemia. Myoken Y, Sugata T, Kyo T, Fujihara M, Mikami Y. J Periodontol; 2002 Jan 06; 73(1):33-8. PubMed ID: 11846198 [Abstract] [Full Text] [Related]
15. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Saag MS, Graybill RJ, Larsen RA, Pappas PG, Perfect JR, Powderly WG, Sobel JD, Dismukes WE. Clin Infect Dis; 2000 Apr 06; 30(4):710-8. PubMed ID: 10770733 [Abstract] [Full Text] [Related]
16. Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trial Group. Wheat J, Hafner R, Korzun AH, Limjoco MT, Spencer P, Larsen RA, Hecht FM, Powderly W. Am J Med; 1995 Apr 06; 98(4):336-42. PubMed ID: 7709945 [Abstract] [Full Text] [Related]
17. Control of invasive pulmonary aspergillosis with oral itraconazole in a bone marrow transplant patient. Denning DW, Stepan DE, Blume KG, Stevens DA. J Infect; 1992 Jan 06; 24(1):73-9. PubMed ID: 1312563 [Abstract] [Full Text] [Related]
18. Amphotericin B with and without itraconazole for invasive aspergillosis: A three-year retrospective study. Popp AI, White MH, Quadri T, Walshe L, Armstrong D. Int J Infect Dis; 1999 Jan 06; 3(3):157-60. PubMed ID: 10460928 [Abstract] [Full Text] [Related]
19. Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trial. Boogaerts M, Winston DJ, Bow EJ, Garber G, Reboli AC, Schwarer AP, Novitzky N, Boehme A, Chwetzoff E, De Beule K, Itraconazole Neutropenia Study Group. Ann Intern Med; 2001 Sep 18; 135(6):412-22. PubMed ID: 11560454 [Abstract] [Full Text] [Related]
20. [Invasive bronchopulmonary aspergillosis treated with itraconazole in a patient with acute leukemia]. Sarcía-Ruiz JC, Alvarez C, Floristán F, Hernández I, Hernández J, Alvarez Blanco A, Ponton J. Sangre (Barc); 1993 Oct 18; 38(5):399-402. PubMed ID: 8140504 [Abstract] [Full Text] [Related] Page: [Next] [New Search]